FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094865988> ?p ?o ?g. }

• W2094865988 endingPage "522" @default.
• W2094865988 startingPage "514" @default.
• W2094865988 abstract "The c-fms proto-oncogene encodes the receptor for a hematopoietic growth factor, CSF-1. Recently, the importance of c-fms and its ligand CSF-1 in malignancies of non-hematopoietic origin, such as breast, ovarian, endometrial, pulmonary, and trophoblastic cancers has been recognized. We have previously shown that glucocorticoids induce a large increase in c-fms mRNA and protein levels in breast carcinoma cell lines. In this report, we investigate the mechanism underlying such c-fms overexpression by dexamethasone. We show that dexamethasone treatment of two breast carcinoma cell lines (BT20-c-fms expressor, and SKBR3-co-expressor of both c-fms and CSF-1) does not increase the rate of c-fms gene transcription, suggesting a post-transcriptional mechanism of regulation of c-fms expression by dexamethasone. The effect of protein synthesis inhibition was studied to help determine whether there was a role for intermediary regulatory proteins in the regulation of c-fms expression. We find that several protein synthesis inhibitors interfere with dexamethasone induction of c-fms transcripts, suggesting the existence of regulatory proteins. These regulatory proteins do not appear to be constitutively expressed, as we show no effect of protein synthesis inhibition on c-fms transcript expression in resting BT20 cells. These findings suggest that the putative regulatory proteins are induced by dexamethasone. Furthermore, the addition of a protein synthesis inhibitor, pactamycin, to dexamethasone-treated BT20 cells results in a decrease in c-fms mRNA stability. There is no decrease of c-fms transcripts over the six hours of actinomycin-D chase in the dexamethasone-treated cells. However, when pactamycin is added to dexamethasone, the calculated c-fms mRNA half-life falls to seven hours, which represents a decrease of c-fms mRNA half-life to that measured in the resting cell, and in monocytes. Taken together, these results suggest the involvement of a dexamethasone-inducible c-fms mRNA stabilizing protein in the regulation of c-fms gene expression in breast carcinoma cell lines. Interestingly, dexamethasone has no effect on CSF-1 expression in SKBR3 cells. Protein synthesis inhibition however results in a reciprocal effect, with induction and stabilization of CSF-1 transcripts, which contrasts with the destabilization of c-fms mRNA. This reciprocal effect led us to postulate that CSF-1 may also contribute to the post-transcriptional regulation of c-fms mRNA expression in breast carcinoma cells. Therefore, the effect of addition of exogenous CSF-1 on c-fms mRNA expression in BT20 cells was studied. We demonstrate that exogenous CSF-1 is able to down-regulate c-fms mRNA expression by 3-fold in BT20 cells. This suggests that CSF-1, in addition to glucocorticoids, may play a role in the post-transcriptional regulation of c-fms expression in breast carcinoma cells. (Steroids 59:514–522, 1994)" @default.
• W2094865988 created "2016-06-24" @default.
• W2094865988 creator A5012137922 @default.
• W2094865988 creator A5034626396 @default.
• W2094865988 creator A5049382137 @default.
• W2094865988 creator A5080149644 @default.
• W2094865988 date "1994-09-01" @default.
• W2094865988 modified "2023-10-18" @default.
• W2094865988 title "Post-transcriptional regulation of c-fms proto-oncogene expression by dexamethasone and of CSF-1 in human breast carcinomas in vitro" @default.
• W2094865988 cites W1029058600 @default.
• W2094865988 cites W1604696091 @default.
• W2094865988 cites W1612855301 @default.
• W2094865988 cites W1839704197 @default.
• W2094865988 cites W1861597294 @default.
• W2094865988 cites W1964846497 @default.
• W2094865988 cites W1971972894 @default.
• W2094865988 cites W1978659501 @default.
• W2094865988 cites W1981827637 @default.
• W2094865988 cites W1987383790 @default.
• W2094865988 cites W2001486328 @default.
• W2094865988 cites W2010724853 @default.
• W2094865988 cites W2013812530 @default.
• W2094865988 cites W2017830116 @default.
• W2094865988 cites W2022122015 @default.
• W2094865988 cites W2025732397 @default.
• W2094865988 cites W2031336219 @default.
• W2094865988 cites W2031436487 @default.
• W2094865988 cites W2037767071 @default.
• W2094865988 cites W2044505782 @default.
• W2094865988 cites W2045228168 @default.
• W2094865988 cites W2048180296 @default.
• W2094865988 cites W2056648716 @default.
• W2094865988 cites W2060333964 @default.
• W2094865988 cites W2064936349 @default.
• W2094865988 cites W2067546038 @default.
• W2094865988 cites W2078280565 @default.
• W2094865988 cites W2090687703 @default.
• W2094865988 cites W2102547528 @default.
• W2094865988 cites W2104360623 @default.
• W2094865988 cites W2105527911 @default.
• W2094865988 cites W2110720259 @default.
• W2094865988 cites W2111476141 @default.
• W2094865988 cites W2113038404 @default.
• W2094865988 cites W2143762467 @default.
• W2094865988 cites W2157409282 @default.
• W2094865988 cites W2160803577 @default.
• W2094865988 cites W2399063565 @default.
• W2094865988 cites W2412477990 @default.
• W2094865988 cites W2419024573 @default.
• W2094865988 cites W300962634 @default.
• W2094865988 cites W42158009 @default.
• W2094865988 cites W4235532947 @default.
• W2094865988 cites W4241531133 @default.
• W2094865988 cites W4247000966 @default.
• W2094865988 doi "https://doi.org/10.1016/0039-128x(94)90069-8" @default.
• W2094865988 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7846733" @default.
• W2094865988 hasPublicationYear "1994" @default.
• W2094865988 type Work @default.
• W2094865988 sameAs 2094865988 @default.
• W2094865988 citedByCount "21" @default.
• W2094865988 countsByYear W20948659882013 @default.
• W2094865988 countsByYear W20948659882017 @default.
• W2094865988 crossrefType "journal-article" @default.
• W2094865988 hasAuthorship W2094865988A5012137922 @default.
• W2094865988 hasAuthorship W2094865988A5034626396 @default.
• W2094865988 hasAuthorship W2094865988A5049382137 @default.
• W2094865988 hasAuthorship W2094865988A5080149644 @default.
• W2094865988 hasConcept C104317684 @default.
• W2094865988 hasConcept C105580179 @default.
• W2094865988 hasConcept C126322002 @default.
• W2094865988 hasConcept C134018914 @default.
• W2094865988 hasConcept C138885662 @default.
• W2094865988 hasConcept C150194340 @default.
• W2094865988 hasConcept C179926584 @default.
• W2094865988 hasConcept C202751555 @default.
• W2094865988 hasConcept C27153228 @default.
• W2094865988 hasConcept C2780401358 @default.
• W2094865988 hasConcept C2781018059 @default.
• W2094865988 hasConcept C29537977 @default.
• W2094865988 hasConcept C41895202 @default.
• W2094865988 hasConcept C502942594 @default.
• W2094865988 hasConcept C55493867 @default.
• W2094865988 hasConcept C71924100 @default.
• W2094865988 hasConcept C86803240 @default.
• W2094865988 hasConcept C95444343 @default.
• W2094865988 hasConceptScore W2094865988C104317684 @default.
• W2094865988 hasConceptScore W2094865988C105580179 @default.
• W2094865988 hasConceptScore W2094865988C126322002 @default.
• W2094865988 hasConceptScore W2094865988C134018914 @default.
• W2094865988 hasConceptScore W2094865988C138885662 @default.
• W2094865988 hasConceptScore W2094865988C150194340 @default.
• W2094865988 hasConceptScore W2094865988C179926584 @default.
• W2094865988 hasConceptScore W2094865988C202751555 @default.
• W2094865988 hasConceptScore W2094865988C27153228 @default.
• W2094865988 hasConceptScore W2094865988C2780401358 @default.
• W2094865988 hasConceptScore W2094865988C2781018059 @default.
• W2094865988 hasConceptScore W2094865988C29537977 @default.
• W2094865988 hasConceptScore W2094865988C41895202 @default.

• next